Cell line name NCC-GCTB4-C1
Accession CVCL_B3VJ
Resource Identification Initiative To cite this cell line use: NCC-GCTB4-C1 (RRID:CVCL_B3VJ)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 65.78 hours (PubMed=34731453).
Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
Sequence variations
Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34731453).
Disease Malignancy in giant cell tumor of bone (NCIt: C4304)
Giant cell tumor of bone (ORDO: Orphanet_363976)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 52Y
Category Cancer cell line
STR profile

Source(s): PubMed=34731453


Amelogenin X,Y
CSF1PO 12,13
D5S818 12
D7S820 10,11
D13S317 8,12
D16S539 9,11
D21S11 28.2,30
TH01 6,9
vWA 17,18

PubMed=34731453; DOI=10.1007/s13577-021-00639-4
Ono T., Noguchi R., Yoshimatsu Y., Tsuchiya R., Sin Y., Nakagawa R., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
Hum. Cell 35:392-399(2022)

Encyclopedic resources Wikidata; Q110433084

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-GCTB4-C1”

Your email address will not be published. Required fields are marked *